Further adding complexity to the mechanisms whereby sympathetic nerves influence breast cancer tumor progression is the difference between pharmacological βAR agonists and endogenous NE released by nerves in terms of adrenergic signaling and action. This evidence concerns the gene ADRB2 and breast carcinoma.